Falling sales, an SEC probe into its business practices and the threat of more Chinese legal woes. Sound familiar? Yes, if you’ve followed the trajectory of Avon Products. However, it appears similar afflictions have been affecting US direct selling beauty company Nu Skin.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cosmetics Business.
Subscribe now Already a subscriber? Sign in here.